Robert Stockton Jones Jr.

Array ( [id] => 5760817 [patent_doc_number] => 20060211762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Omega-3 fatty acids and dyslipidemic agent for lipid therapy' [patent_app_type] => utility [patent_app_number] => 11/284095 [patent_app_country] => US [patent_app_date] => 2005-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8983 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211762.pdf [firstpage_image] =>[orig_patent_app_number] => 11284095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 217170 [patent_doc_number] => 07612080 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-03 [patent_title] => 'GTPase inhibitors and use thereof for controlling platelet hyperactivity' [patent_app_type] => utility [patent_app_number] => 11/283556 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 18 [patent_no_of_words] => 20133 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/612/07612080.pdf [firstpage_image] =>[orig_patent_app_number] => 11283556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5029050 [patent_doc_number] => 20070270497 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'Agent For Recovery From Cerebral Fatigue' [patent_app_type] => utility [patent_app_number] => 11/718894 [patent_app_country] => US [patent_app_date] => 2005-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 3510 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20070270497.pdf [firstpage_image] =>[orig_patent_app_number] => 11718894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5829151 [patent_doc_number] => 20060063781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Pharmaceutical composition for regeneration of cirrhotic liver' [patent_app_type] => utility [patent_app_number] => 11/261884 [patent_app_country] => US [patent_app_date] => 2005-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5010 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063781.pdf [firstpage_image] =>[orig_patent_app_number] => 11261884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9454720 [patent_doc_number] => 08715724 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-06 [patent_title] => 'Tabletting process' [patent_app_type] => utility [patent_app_number] => 11/666354 [patent_app_country] => US [patent_app_date] => 2005-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 6835 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11666354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5743687 [patent_doc_number] => 20060089412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Pharmaceutical composition for the treatment of non-alcoholic fatty liver disease' [patent_app_type] => utility [patent_app_number] => 11/251932 [patent_app_country] => US [patent_app_date] => 2005-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2300 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20060089412.pdf [firstpage_image] =>[orig_patent_app_number] => 11251932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 131982 [patent_doc_number] => 07700653 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-20 [patent_title] => 'Halogen-substituted aminodicarboxylic acid derivatives' [patent_app_type] => utility [patent_app_number] => 11/210131 [patent_app_country] => US [patent_app_date] => 2005-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7339 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/700/07700653.pdf [firstpage_image] =>[orig_patent_app_number] => 11210131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5902525 [patent_doc_number] => 20060045905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-02 [patent_title] => 'Composition for repressing transformation growth factor beta' [patent_app_type] => utility [patent_app_number] => 11/209126 [patent_app_country] => US [patent_app_date] => 2005-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4105 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20060045905.pdf [firstpage_image] =>[orig_patent_app_number] => 11209126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7244233 [patent_doc_number] => 20050271721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Carvedilol-hydrophilic solutions' [patent_app_type] => utility [patent_app_number] => 11/204614 [patent_app_country] => US [patent_app_date] => 2005-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4435 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0271/20050271721.pdf [firstpage_image] =>[orig_patent_app_number] => 11204614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6930857 [patent_doc_number] => 20050281892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Anti-tumor composition' [patent_app_type] => utility [patent_app_number] => 11/196454 [patent_app_country] => US [patent_app_date] => 2005-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6122 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20050281892.pdf [firstpage_image] =>[orig_patent_app_number] => 11196454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4965883 [patent_doc_number] => 20080108703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'Methods for Improving Bioavailability of a Renin Inhibitor' [patent_app_type] => utility [patent_app_number] => 11/572471 [patent_app_country] => US [patent_app_date] => 2005-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6602 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20080108703.pdf [firstpage_image] =>[orig_patent_app_number] => 11572471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5205727 [patent_doc_number] => 20070027209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Prevention and treatment of atherosclerosis with lithospermate B' [patent_app_type] => utility [patent_app_number] => 11/193355 [patent_app_country] => US [patent_app_date] => 2005-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5640 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20070027209.pdf [firstpage_image] =>[orig_patent_app_number] => 11193355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4720203 [patent_doc_number] => 20080242726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Trans-Clomiphene for the Treatment of Benign Prostate Hypertrophy, Porstate Cancer, Hypogonadism Elevated Triglycerides and High Cholesterol' [patent_app_type] => utility [patent_app_number] => 11/571150 [patent_app_country] => US [patent_app_date] => 2005-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6709 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20080242726.pdf [firstpage_image] =>[orig_patent_app_number] => 11571150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6967155 [patent_doc_number] => 20050234052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Treatment for ocular infections' [patent_app_type] => utility [patent_app_number] => 11/159897 [patent_app_country] => US [patent_app_date] => 2005-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3235 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20050234052.pdf [firstpage_image] =>[orig_patent_app_number] => 11159897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5748516 [patent_doc_number] => 20060111448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Methods for treating cognitive impairment in humans with multiple sclerosis' [patent_app_type] => utility [patent_app_number] => 11/133144 [patent_app_country] => US [patent_app_date] => 2005-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 64899 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20060111448.pdf [firstpage_image] =>[orig_patent_app_number] => 11133144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6931716 [patent_doc_number] => 20050282751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Therapeutic agent for renal anemia' [patent_app_type] => utility [patent_app_number] => 11/082917 [patent_app_country] => US [patent_app_date] => 2005-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3415 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282751.pdf [firstpage_image] =>[orig_patent_app_number] => 11082917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5141295 [patent_doc_number] => 20070003511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Lipid combination to combat ashy skin' [patent_app_type] => utility [patent_app_number] => 11/083549 [patent_app_country] => US [patent_app_date] => 2005-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5113 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20070003511.pdf [firstpage_image] =>[orig_patent_app_number] => 11083549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5005521 [patent_doc_number] => 20070203093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Antistress Agent' [patent_app_type] => utility [patent_app_number] => 11/631618 [patent_app_country] => US [patent_app_date] => 2005-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7351 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20070203093.pdf [firstpage_image] =>[orig_patent_app_number] => 11631618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 270226 [patent_doc_number] => 07563460 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-21 [patent_title] => 'Enteric coated oral pharmaceutical to erode kidney stones' [patent_app_type] => utility [patent_app_number] => 11/066621 [patent_app_country] => US [patent_app_date] => 2005-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2081 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/563/07563460.pdf [firstpage_image] =>[orig_patent_app_number] => 11066621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5070345 [patent_doc_number] => 20070191447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Novel heterocyclic compound' [patent_app_type] => utility [patent_app_number] => 10/590157 [patent_app_country] => US [patent_app_date] => 2005-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28706 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191447.pdf [firstpage_image] =>[orig_patent_app_number] => 10590157 [rel_patent_id] =>[rel_patent_doc_number] =>)